US Stocks Movement: Celcuity plunges on October 7 due to commercialization pressure and widening losses

Celcuity October 7th Analysis of Sharp Decline

Keywords: Commercialization pressure, expanding losses

1. On September 30, 2026, the company announced that REVTORPYK was listed in the United States, but has yet to disclose any commercial sales data. The stock price catalyst has shifted from the initial listing to expectations of revenue realization, increasing short-term volatility. 2. On August 13, 2026, the company’s net loss for the second quarter widened to approximately $78.86 million. The start of commercialization has been accompanied by increased investment in research and development, sales, and infrastructure, and ongoing losses continue to exert valuation pressure.

(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)